Additional therapy for the patients with early gastric cancer after endoscopic submucosal dissection

Additional therapy for the patients with early gastric cancer after endoscopic submucosal dissection - Additional therapy for the patients with early gastric cancer after endoscopic submucosal dissection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007430

Enrollment

150

Registered

2012-03-02

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

Absolute criteria of endoscopic submucosal dissection for gastric cancer Expanded criteria of endoscopic submucosal dissection for gastric cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) histologically proven gastric adenocarcinoma (2) solitary tumor (3) no prior treatment (4) age 20-80 years (5) sufficient organ function

Exclusion criteria

Exclusion criteria: (1) synchronous or metachronous malignancy

Design outcomes

Primary

Measure	Time frame
Incidence of lymph node metastasis, clinicopathological character, complication, overall survival and disease-free survival	—

Countries

Japan

Contacts

Public ContactHiroaki Ito, MD, PhD

Showa University Northern Yokohama Hospital Digestive Disease Center

h.ito@med.showa-u.ac.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026